The Strategy Catalyst Dispatch Podcast By The Health Management Academy cover art

The Strategy Catalyst Dispatch

The Strategy Catalyst Dispatch

By: The Health Management Academy
Listen for free

The Strategy Catalyst Dispatch brings healthcare strategy professionals into the room with leading health system executives to explore how innovation, clinical leadership, and enterprise strategy intersect. Designed for strategy executives, physician leaders, and healthcare innovators, the podcast offers actionable takeaways to help organizations drive both clinical and financial impact.

© 2026 The Strategy Catalyst Dispatch
Economics Management Management & Leadership
Episodes
  • The Strategist in Brief: March 12, 2026
    Mar 12 2026

    This week's episode covers the American Medical Association's new maternity payment codes, our new CSO Advisory Council, health system access strategy survey results, and insights on consumer segmentation.

    Show more Show less
    3 mins
  • Service Line Disruptors 2026: Pay-Viders, PE, and the Threat You're Not Watching
    Feb 27 2026

    In this episode, we share highlights from a recent Strategy Catalyst webinar where Liz Jones, Research Director, walked strategy leaders through three disruptors reshaping service lines in 2026 and tested a few intentionally provocative predictions. We cover why payvider M&A slowdowns don't mean reduced threat, what the PE retreat from care delivery means for acquisition timing, and why distributors—the disruptor that worried this group least—might deserve more attention.

    Want to hear the full discussion, including the polls and live Q&A? Strategy Catalyst members can access the complete webinar recording on our website here. And for a deeper dive on the Cencora-One Oncology deal referenced in this episode, read our analysis in The Strategist here and check out our disruptor response guide here.

    Show more Show less
    26 mins
  • The Strategist in Brief: February 26, 2026
    Feb 26 2026

    This week's episode covers Humana's acquisition of MaxHealth, the Trump administration's antitrust appeal, the Supreme Court's tariff ruling, CMS's new ACCESS model rates, and CVS's new GLP-1 drug access service.

    Show more Show less
    3 mins
No reviews yet